Geode Capital Management LLC Purchases 179,103 Shares of Senseonics Holdings, Inc. (NYSE:SENS)

Geode Capital Management LLC raised its position in Senseonics Holdings, Inc. (NYSE:SENS) by 3.2% during the third quarter, according to its most recent filing with the SEC. The firm owned 5,838,396 shares of the company’s stock after purchasing an additional 179,103 shares during the period. Geode Capital Management LLC’s holdings in Senseonics were worth $2,042,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. FMR LLC increased its position in shares of Senseonics by 48,267.2% during the third quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after acquiring an additional 167,970 shares in the last quarter. GSA Capital Partners LLP acquired a new position in Senseonics during the 3rd quarter valued at about $117,000. Cubist Systematic Strategies LLC increased its holdings in Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after purchasing an additional 85,501 shares in the last quarter. Finally, Symmetry Partners LLC purchased a new stake in shares of Senseonics in the third quarter worth approximately $164,000. 12.36% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SENS. StockNews.com started coverage on shares of Senseonics in a report on Thursday, December 26th. They set a “sell” rating on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $2.00 target price on shares of Senseonics in a report on Friday, November 15th.

Senseonics Stock Performance

Shares of SENS opened at $0.43 on Thursday. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47. The stock has a market capitalization of $256.23 million, a price-to-earnings ratio of -3.31 and a beta of 0.64. Senseonics Holdings, Inc. has a 52-week low of $0.25 and a 52-week high of $0.75. The stock’s 50-day simple moving average is $0.38 and its 200 day simple moving average is $0.38.

Insiders Place Their Bets

In other news, CEO Timothy T. Goodnow purchased 315,000 shares of Senseonics stock in a transaction that occurred on Tuesday, December 10th. The shares were bought at an average cost of $0.31 per share, with a total value of $97,650.00. Following the completion of the purchase, the chief executive officer now directly owns 11,310,355 shares in the company, valued at approximately $3,506,210.05. This trade represents a 2.86 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Frederick T. Sullivan acquired 124,933 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The shares were acquired at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the purchase, the chief financial officer now directly owns 2,478,844 shares of the company’s stock, valued at $941,960.72. This represents a 5.31 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.60% of the company’s stock.

Senseonics Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.